You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 4,826,821


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,826,821
Title: Lung surfactant compositions
Abstract:An improved synthetic lung surfactant consists essentially of dipalmitoyl phosphatidyl choline, a C-14 to C-18 fatty alcohol (preferably hexadecanol), and a non-toxic nonionic surface active agent (preferably tyloxapol). The surfactant is prepared in a powdered lyophilized form that can be stored for extended periods at room temperature. The powdered product can be readily reconstituted by simply adding distilled water.
Inventor(s): Clements; John A. (Tiburon, CA)
Assignee: The Regents of the University of California (Berkeley, CA)
Application Number:06/927,340
Patent Claim Types:
see list of patent claims
Composition; Formulation;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of U.S. Patents: A Detailed Analysis

Introduction

Patents are a cornerstone of innovation, providing inventors and companies with exclusive rights to their inventions. In the United States, the patent system is governed by a complex set of laws and regulations. This article will delve into the specifics of U.S. patents, focusing on the scope and claims, using the example of U.S. Patent 4,826,821 to illustrate key concepts.

The Patent System in the United States

The U.S. patent system is administered by the United States Patent and Trademark Office (USPTO). The Leahy-Smith America Invents Act (AIA) of 2011 is a significant piece of legislation that has shaped modern U.S. patent law, introducing the Patent Trial and Appeal Board (PTAB) and new types of administrative challenges to patent validity[1].

Patentability Requirements

For an invention to be patentable, it must meet several criteria:

Novelty Requirement

The invention must be new and not previously disclosed in the prior art. This means that every element of the claimed invention must not have been available to the public before the effective filing date of the patent application[1].

Nonobviousness Requirement

The invention must be nonobvious, meaning it must be significantly different from existing knowledge and not an obvious improvement over prior art[1].

Subject Matter Eligibility

The invention must be directed to eligible subject matter, such as not being a law of nature, natural phenomenon, or abstract idea. If it is directed to ineligible subject matter, it must have an "inventive concept" that transforms the nature of the claim[1].

Determining Inventorship

Inventorship is a critical aspect of patent law. Only the true and only inventors are entitled to a patent. The process involves two steps: conception of the idea and reduction of the idea to practice. Incorrect or incomplete identification of inventors can lead to a patent being invalid or unenforceable[2].

The Role of the Patent Trial and Appeal Board (PTAB)

The PTAB is a tribunal within the USPTO that hears administrative challenges to the validity of patents. These challenges include Inter Partes Review (IPR) and Post-Grant Review (PGR), which allow anyone to challenge patents before the USPTO. These processes are often faster and less expensive than judicial proceedings and require a lower burden of proof to invalidate patents[1].

Patent Claims

Patent claims define the scope of the invention and are crucial for determining what is protected by the patent. The USPTO provides detailed datasets on patent claims, including the Patent Claims Research Dataset, which contains information on claims from U.S. patents granted between 1976 and 2014 and patent applications published between 2001 and 2014[3].

Types of Claims

  • Independent Claims: These claims stand alone and define the invention without reference to other claims.
  • Dependent Claims: These claims refer back to and further limit an independent claim.

Claim Construction

The interpretation of patent claims is a critical step in determining the scope of a patent. This process involves analyzing the language of the claims, the specification, and the prosecution history of the patent[1].

Example: U.S. Patent 4,826,821

To illustrate these concepts, let's consider U.S. Patent 4,826,821, though the specific details of this patent are not provided here. Here’s how the general principles apply:

Patentability Requirements

  • Novelty: The invention described in the patent must have been new at the time of filing.
  • Nonobviousness: The invention must have been significantly different from prior art.
  • Subject Matter Eligibility: The invention must be directed to eligible subject matter.

Claims Analysis

  • Independent Claims: These would define the core aspects of the invention.
  • Dependent Claims: These would further limit the independent claims, often adding specific details or variations.

Inventorship

The patent would list the true and only inventors who conceived and reduced the invention to practice.

Challenges to Patent Validity

Patents can be challenged through various mechanisms, including IPR and PGR before the PTAB, or through judicial proceedings. These challenges can be based on issues such as prior art, obviousness, or subject matter eligibility[1].

The Importance of Accurate Claim Drafting

Accurate and clear claim drafting is essential for defining the scope of a patent. Poorly drafted claims can lead to ambiguity and potential invalidation of the patent. Here is a highlight from the USPTO on the importance of claim drafting:

"The patent claims must contain elements ‘sufficient to ensure that the patent in practice amounts to significantly more than a patent upon the [ineligible concept] itself,’ transforming the nature of the claim to a patent-eligible application of ineligible subject matter."[1]

Global Dossier and Public Search Facilities

The USPTO provides tools like the Global Dossier and the Public Search Facility to help users access and analyze patent information. The Global Dossier allows users to see the patent family for a specific application, including related applications filed at participating IP Offices, along with dossier, classification, and citation data[4].

Future Directions: Small Claims Patent Court

There is ongoing discussion about the feasibility of a small claims patent court, which could provide a more accessible and cost-effective way for small entities to resolve patent disputes. The Administrative Conference of the United States (ACUS) has conducted studies and gathered public comments on this topic[5].

Key Takeaways

  • Patentability Requirements: Inventions must be novel, nonobvious, and directed to eligible subject matter.
  • Inventorship: Correct identification of inventors is crucial for patent validity.
  • Patent Claims: Claims define the scope of the invention and must be carefully drafted.
  • Challenges to Validity: Patents can be challenged through administrative and judicial proceedings.
  • Global Dossier and Public Search: Tools are available to facilitate access to patent information.

FAQs

What is the role of the Patent Trial and Appeal Board (PTAB)?

The PTAB is a tribunal within the USPTO that hears administrative challenges to the validity of patents, including Inter Partes Review (IPR) and Post-Grant Review (PGR).

Why is accurate claim drafting important?

Accurate claim drafting is essential for defining the scope of a patent clearly and avoiding potential invalidation due to ambiguity or other issues.

How can patents be challenged?

Patents can be challenged through IPR and PGR before the PTAB or through judicial proceedings in court.

What is the significance of the Leahy-Smith America Invents Act (AIA)?

The AIA is a significant piece of legislation that introduced the PTAB and new types of administrative challenges to patent validity, aiming to improve patent quality and efficiency.

What tools does the USPTO provide for accessing patent information?

The USPTO provides tools such as the Global Dossier and the Public Search Facility to help users access and analyze patent information.

Sources

  1. Congressional Research Service, "The Patent Trial and Appeal Board and Inter Partes Review," Updated May 28, 2024.
  2. Oregon State University, "Determining Inventorship for US Patent Applications."
  3. USPTO, "Patent Claims Research Dataset."
  4. USPTO, "Search for patents."
  5. Administrative Conference of the United States, "U.S. Patent Small Claims Court."

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 4,826,821

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 4,826,821

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Mexico 9203533 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.